EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cancer Specific CAIX‐Targeting Supramolecular Lysosome‐Targeting Chimeras (Supra‐LYTAC) for Targeted Protein Degradation

Dohyun Kim, Gyeongseok Yang, Chaelyeong Lim, Gaeun Park, Jaemo Lee, Youjung Sim, Ja-Hyoung Ryu iD

Advanced Science · 2025-07 · 12 (26)

DOI: 10.1002/advs.202503134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 03.04.2025. Verfasst von Dohyun Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Ulsan National Institute of Science and Technology (UNIST), 50, UNIST-gil, Eonyang-eup, Ulju-gun, Ulsan, 44919, Republic of Kor…. Hauptthemen laut MEDLINE: Lysosomes, Carbonic Anhydrase IX, Neoplasms, Antigens, Neoplasm. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, targeted protein degradation (TPD) strategies have emerged as a promising solution to tackle undruggable proteins. While most TPD strategies target intracellular proteins, limited options exist for targeting extracellular or membrane proteins. Herein, cancer specific carbonic anhydrase IX (CAIX)‐targeting supramolecular nanofibrous lysosome‐targeting chimeras (Supra‐LYTAC) is reported. Two self‐assembling amphiphilic peptides are synthesized: one that interacts with the protein of interest (POI), and another that mediates lysosomal endocytosis by targeting a cancer‐specific enzyme. Notably, these two peptides co‐assemble into nanofibers capable of targeting cancer cells in a spatiotemporal manner. Through dynamic and multivalent binding, a ternary complex form (supramolecular chimeric nanostructure; CAIX‐nanofiber‐POI), which undergoes internalization into lysosomes where the POI is degraded through lysosomal catalytic activity. This study demonstrates the potential of supramolecular approaches to expand the scope of LYTAC technology, offering new opportunities for designing TPD strategies in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysosomesCarbonic Anhydrase IXNeoplasmsAntigens, NeoplasmHumansProteolysisNanofibersCell Line, TumorPeptides

Stichwörter der Autor:innen

Supramolecular assemblycarbonic anhydrase IXlysosome‐targeting chimeraspeptide amphiphiletargeted protein degradation

Substanzen

Carbonic Anhydrase IXCA9 protein, humanPeptidesAntigens, Neoplasm

Autor:innen und Institutionen

  • Chemistry Department, Ulsan National Institute of Science and Technology (UNIST), 50, UNIST-gil, Eonyang-eup, Ulju-gun, Ulsan, 44919, Republic of Korea.

ORCID-Profile: Ja-Hyoung Ryu

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Kim, D., Yang, G., Lim, C., Park, G., Lee, J., Sim, Y., & Ryu, J. H. (2025). Cancer Specific CAIX‐Targeting Supramolecular Lysosome‐Targeting Chimeras (Supra‐LYTAC) for Targeted Protein Degradation. Advanced Science, 12(26). https://doi.org/10.1002/advs.202503134

Vancouver

Kim D, Yang G, Lim C, Park G, Lee J, Sim Y, et al. Cancer Specific CAIX‐Targeting Supramolecular Lysosome‐Targeting Chimeras (Supra‐LYTAC) for Targeted Protein Degradation. Advanced Science. 2025;12(26). doi:10.1002/advs.202503134

BibTeX
@article{Kim2025,
  author = {Kim, Dohyun and Yang, Gyeongseok and Lim, Chaelyeong and Park, Gaeun and Lee, Jaemo and Sim, Youjung and Ryu, Ja-Hyoung},
  title = {Cancer Specific CAIX‐Targeting Supramolecular Lysosome‐Targeting Chimeras (Supra‐LYTAC) for Targeted Protein Degradation},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {26},
  doi = {10.1002/advs.202503134}
}
Kostenlos starten →